Bevacizumab and Retinal Vascular Occlusions

Asociación para Evitar la Ceguera en México

Status and phase: Withdrawn; Phase 3

Conditions: Edema Macular; Vascular Occlusion

Treatments: Drug: Intravitreal injection

Study type: Interventional

Funder types: Other

Identifiers

NCT00347711

APEC-0020

Details and patient eligibility

About

To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

Sex: All

Ages: 40 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography

Exclusion criteria

• Previous surgery
• Uveitis
• Glaucoma